NCT00581100View on ClinicalTrials.gov

Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions
Nail PsoriasisPlaque Psoriasis
Interventions
DRUG

etanercept

"Subjects randomized to Arm 1 shall be treated with ETN 50 mg twice weekly for 12 weeks reducing thereafter to ETN 50 mg once weekly to 24 weeks.~Subjects randomized to Arm 2 shall be treated with ETN 50 mg once weekly for the entire 24 week treatment period."

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00581100 - Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis | Biotech Hunter | Biotech Hunter